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Abstract—We demonstrate a proof of concept highly 
miniaturised fluorescence imager and its application to detecting 
cancer in resected human colon cancer tissues. Fluorescence 
imaging modalities have already been successfully implemented in 
traditional endoscopy. However, the procedure still causes 
discomfort and requires sedation. Wireless fluorescence capsule 
endoscopy has the potential to improve diagnostic accuracy with 
less inconvenience for patients. In this paper we present a 5 mm x 
6 mm x 5 mm optical block that is small enough to integrate into a 
capsule endoscope. The block integrates ultrathin filters for 
optical isolation and was successfully integrated with a sensitive 
CMOS SPAD array to detect green fluorescence from Flavin 
Adenine Dinucleotide (FAD), which is an endogenous fluorophore 
responsible for autofluorescence in human tissues, and 
fluorescence from the cancer selective molecular probe 
ProteoGREENTM-gGlu used to label colorectal cancer cells. In 
vitro studies were validated using a commercial ModulusTM 
Microplate reader. The potential use of the device in capsule 
endoscopy was further validated by imaging healthy and 
malignant resected human tissues from the colon to detect changes 
in autofluorescence signal that are crucial for cancer diagnosis.   
 
Index Terms—early diagnosis, miniaturisation, capsule 
endoscopy, fluorescence imaging, bowel cancer, autofluorescence, 
fluorescence labelling, CMOS, SPAD, ultra-thin optical filters 
 
I. INTRODUCTION 
N 2001, the U.S. Food and Drug Administration (FDA) 
approved the use of capsule endoscopy (CE) as an auxiliary 
method for the investigation of the small bowel; otherwise 
inaccessible by traditional endoscopic procedures[1]. 
Clinicians have also shown the use of CE in the large bowel for 
determining the location of several gastrointestinal (GI) 
diseases such as Obscure Gastrointestinal Bleeding (OGIB), 
malignant or benign neoplastic lesions (polyps) and celiac 
disease [2]. The optical system of CE usually consists of white 
light emitting diodes (LEDs), short focal length lenses and a 
CMOS image sensor [1].  
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In the early stages of cancer, many lesions cause no 
substantial morphological changes in the GI walls and are 
undetectable by white light imaging (WLI)[3]. As a result, 
diagnosis might become inaccurate. A better detection and 
classification of suspicious areas in the GI mucosa can be 
achieved by using new imaging modalities such as 
autofluorescence imaging (AFI)[4]. This technique has been 
successfully implemented in traditional endoscopes exploiting 
a fibre optic bundle connected to external units to obtain a 
fluorescence image [5].  
In AF endoscopy, fluorescence light is detected by exploiting 
the natural fluorescence of human tissues with  blue light 
illumination[6]. Healthy areas will emit green autofluorescence 
while diseased areas will appear as darker regions [4], [7], [8].  
A different methodology involves targeting lesions with 
cancer-selective molecular fluorescence probes[9]–[11]. 
Specific probes are not intrinsically fluorescent but undergo 
reactions with metabolites, overexpressed in carcinogenic 
environment, that change their molecular structures producing 
highly fluorescent products [9], [12]–[14]. As opposed to the 
AFI, here the cancerous areas show a higher fluorescent signal 
with respect to the surrounding healthy tissues[12], [15]. 
Implementation of fluorescence imaging in capsule endoscopy 
could potentially exploit both methodologies leading to a more 
accurate diagnosis of cancer in the GI tract. 
A miniaturised system for detecting variation in the 
concentration of fluorescence dye in aqueous solution was 
implemented in 2011[16]. Two years later, a tethered 
fluorescence sensor for detection of fluorescence dyes in the 
blood stream was developed[17].  A prototype for measuring 
infrared fluorescence emitted by indocyanine green (IG) used 
as contrast for cancer detection was demonstrated by 
Demosthenous et al.[18]. All these systems were developed to 
offer fluorescence measurements from within the body without 
offering imaging capabilities. A proof of concept capsule for 
AFI of the GI tract has been demonstrated [19]. However, it 
exceeded the acceptable target for capsule endoscopy[20].  
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The challenge is to design an optical system capable of 
imaging small changes in fluorescence signal while being small 
enough to fit in a capsule that will meet the standard medical 
requirements[21]. 
Here we present a low-cost miniaturised optical block (5 mm 
W x 6 mm L x 5 mm H), capable of performing both AFI and 
fluorescence labelling imaging, with dimensions suitable for 
integration in a capsule for endoscopy. The optical unit consists 
of a LED, miniature lenses and ultrathin optical filters to 
minimize the interference between excitation and fluorescence 
light. The imager was completed and tested using a sensitive 64 
x 64 Single Photon Avalanche Diode (SPAD) CMOS chip[22].  
The system was characterized by imaging phantom FAD 
solutions. Moreover, fluorescence from colorectal cancer cells 
labelled with cancer-selective ProteoGREEN™-gGlu was 
successfully detected. The labelling performance of the cancer 
selective probe was compared to the performance of the generic 
fluorescence dye CellTracker™ Green for monitoring cells 
movement. Results were validated by using a ModulusTM 
microplate reader. Finally, the system was used to image 
autofluorescence signals from healthy and malignant ex vivo 
human tissues from the colon.   
II. MATERIALS AND METHODS 
A. Optical Block 
The optical design of the block was realized using Zemax 
Optics Studio. The body accommodating the optical 
components was designed using SolidWorks.  
The block is made of aluminium and consists of an aperture 
and slots for fitting lenses and filters. The precise position of 
the slots was achieved using a standard wire erosion process. 
The slots were designed with a tolerance of 100 µm with respect 
to the final sizes of the optical components. The block was 
anodized and painted black to minimize unwanted reflections 
of light near the optical path (Fig. S1 (a), (b), Supplementary 
Information).  
The final dimensions of the block are 5 mm W x 6 mm L x 5 
mm H. The components used were a LED (Broadcom Limited 
ASMT-BB20-NS000), collimation lens (Edmund Optics), 
excitation filter (480/17 nm BrightLine®, Semrock), dichroic 
beam splitter (506 nm edge BrightLine®, Semrock), objective 
lens (84-124, Edmund Optics) and fluorescence filter (529/28 
nm BrightLine®, Semrock) (Fig. S1 (c), Supplementary 
Information). The thickness of the as-bought filters was not 
                                                
                       
 
Fig. 1. Miniaturised optical block for fluorescence imaging in capsule endoscopy.  (a) Cross-section model of the optical block consisting of an LED, collimation 
lens, excitation filter, beam splitter, fluorescence filter and objective lens.  (b) Final assembled optical block prototype. (c) Optical simulation of the block showing 
the excitation light from the LED filtered and reflected on the sample and fluorescence light from the sample imaged by the objective lens onto the detector after 
passing through the fluorescence filter. (d) Optical transmission properties of the excitation filter, beam splitter and fluorescence filter incorporated in the block. 
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suitable for integration into the block, therefore lapping and 
polishing were needed to reach the required thickness to 
optimize miniaturisation (Fig. S2, Supplementary Information). 
Specifically, the thickness of the excitation and fluorescence 
filters was reduced from 2 mm to 500 µm whereas the beam 
splitter thickness was reduced from 1.2 mm to 200 µm. 
Transmission and reflection properties of the filters were 
measured before and after lapping and polishing by using a 
micro-spectrophotometer (Foster + Freeman ffTA/MS) to 
ensure that the fabrication process did not affect their optical 
performance (Fig. S3 Supplementary Information). 
B. 64 x 64 CMOS-chip SPAD array 
The SPAD chip was fabricated by AMS AG in a legacy 
unmodified 180 nm high voltage (HV) CMOS process. The 
sensor chip has a 64 × 64 array of pixels and was designed using 
Cadence Virtuoso software package. Each pixel is a SPAD 
biased in Geiger mode to detect single photons of light 
impinging the active area.  An ST nucleo F338R8 Mbed board 
was programmed to interface the chip to a laptop and read count 
events from the chip (Fig. S4, Supplementary Information). A 
Matlab algorithm synchronized and read the data on a serial port 
and then reconstructed the data into an image with a frame rate 
of 1.3 fps. The imager array was characterized in previous 
work[22]. 
C. Imaging Setup 
The SPAD chip was mounted on to the side of the optical 
block using a black nylon disk with an aperture in the centre as 
a spacer. The module was in turn mounted on to a PCB that also 
carried the microcontroller and read-out electronics. The 
imager assembly was mounted on to an optical breadboard. 
Also located on the breadboard was a set of motorized X-Y-Z 
optical stages so as to position and manipulate objects to be 
imaged with respect to the fluorescence imaging cube (Fig. S5, 
Supplementary Information). The exit pupil of the optical block 
was 2 mm in diameter whereas the SPAD imaging array was 
3.9 mm x 3.9 mm. Since the outer regions of the array were not 
used, a software mask was used to exclude the dark outer pixels 
(Fig. S6, Supplementary Information).  
Before imaging any sample, the optical system was placed in 
an enclosed dark space to evaluate the effect of the noise 
sources. The Dark Count Rate (DCR) is the number of events a 
SPAD reads in the absence of light arising from thermal 
excitation and band-to-band tunnelling.  In our imaging system, 
another component of noise was from stray light as a 
consequence of the small amount of excitation light coming 
from the LED that is scattered on to the SPAD. DCR was 
measured by taking 10 frames in a dark environment with the 
LED turned off. The same process was repeated with the LED 
turned on to evaluate the noise introduced by the LED into the 
system. The ten frames were averaged in a single frame. All 
experiments were performed at fourteen different sample 
intervals for the SPADs in the array[22]. The average noise was 
computed only for the pixels within the aforementioned 
software mask. The DCR and stray-light noise plot is shown in 
figure S7, in the supplementary information section. 
 
D. Fluorescence Phantom Solutions Experiments 
Flavin adenine dinucleotide salt hydrate (molecular mass 
829.5 g/mol, purity> 95% Sigma Aldrich) was dissolved in 
Phosphate Buffer Saline (PBS) to obtain six separate phantom 
solutions at concentrations of 250 µM, 125 µM, 60 µM, 30 µM, 
15 µM, and 7.5 µM respectively. 
A 3" x 3" Positive Fluorescent, 1951 USAF Target mask 
(Edmund Optics) was placed on the objective stage. The mask 
consisted of a layer of chromium into which transparent 
features were etched.  
10 µL Flavin solutions were separately pipetted on to a 625 
μm x 625 μm open square window on the USAF mask. The six 
separate solutions with different concentrations were imaged 
using the imager. The average of all the pixels within the 
fluorescence feature was computed for each concentration. 
Experiments were replicated three times per concentration. The 
software mask described previously in the text was subtracted 
from the images in order to account only for the fluorescence 
signal emitted by the phantom solutions. 
E. In vitro Experiments 
CellTracker™ Green CMFDA Dye is a fluorescence dye for 
monitoring cell location designed to work with all cell types. It 
was purchased from Thermofisher and dissolved in 20 µL of 
anhydrous dimethyl sulfoxide (DMSO) to make a stock 
solution of 1 mM. The stock solution was diluted in Hank 
balanced salt solution (HBSS) to make 1µM, 2µM and 5µM 
cell stain solution.  
Cancer-selective probe ProteoGreenTM-gGlu was purchased 
from Goryo Chemical and dissolved in 29.7 µL of DMSO to 
prepare a 1mM stock solution. The stock solution was diluted 
with HBBS to make 1µM, 2µM and 5µM cell stain solution.   
Dukes' type B colorectal adenocarcinoma cell line LS 174T 
(ATCC® CL­188™) and human hTERT-immortalized 
foreskin fibroblast cell line BJ­5ta (ATCC® CRL­4001™) 
where purchased and sub-cultured in two separate 75 cm2 flasks 
at 37° C in 5% CO2 atmosphere. The fibroblasts were used as 
negative control for the cancer-selective probe. 
Cultures with specified seeding densities of 100000 
cells/cm2, 25000 cells/cm2, 6250 cells/cm2, and 1562 cells/cm2 
were replicated four times each within a 96 well plate (Fig. S8 
(a), Supplementary Information). Four additional wells per 
plate were pipetted with culture medium only, for control 
purposes. The protocol was followed using separate plates for 
hTERT-immortalized foreskin fibroblast and Dukes' type B 
colorectal adenocarcinoma cell populations. The protocol is 
pictured in figure S8 (a) of the supplementary information 
section. ProteoGreenTM-gGlu and CellTracker™ Green were 
used to label plates cultured with the adenocarcinoma cancer 
cells prepared following the aforementioned culture protocol. 
Three separate plates for each dye were labelled with 
concentrations of 5µM, 2µM and 1µM respectively. Three 
other plates were not stained to assess the fluoresce signal from 
cells without any fluorescence label. Moreover, three plates 
cultured with the negative control hTERT-immortalized 
foreskin fibroblast cells were also separately labelled with 
concentrations of 5µM, 2µM and 1µM of ProteoGreenTM-gGlu. 
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The optical fluorescence signal from the cells stained with 
the fluorescence probes was expected to change as a function 
of the cell density in the wells. Since the field of view of the 
imager was 2 mm and the well diameter was 6.3 mm, it was 
necessary to scan the wells over the imager to capture a 
representative signal (Fig. S8 (b), Supplementary Information). 
The data from each pixel in each of the frame that made a single 
scan were averaged together. This procedure was also carried 
out for the wells containing only culture medium to determine 
control replicate 𝑴 ̅̅̅̅ which was subtracted from the data.  For 
each plate, the average fluorescence value ?̅?(𝒔)where s denotes 
the seeding density was calculated by averaging the values from 
all four wells cultured with the same seeding densities within 
the same plate. Three plates for each concentration of dye were 
measured. The final fluorescence value for each seeding density 
at a specific dye concentration was computed by averaging the 
values obtained from the three experiments at the specific 
seeding density. The procedure was also performed on three 
plates without any labelling probes to assess the fluorescence 
from the unstained cells at the aforementioned four seeding 
densities. The same experimental procedure was performed by 
using the ModulusTM Microplate reader. In this case, no 
scanning was required as the system directly provided a 
representative fluorescence signal from each well. 
F. Ex-vivo Experiments 
Appropriate institutional ethical consent and pre-operative 
patient consent were obtained for the acquisition of tissue 
specimens. Portions of normal colon and cancer tissue (5mm2) 
were collected fresh, within 30 minutes, from patients 
undergoing surgical resection (right hemicolectomy) for 
adenocarcinoma of the colon.  Before imaging any tissue, 
images of the surface of an empty petri dish were acquired to 
account for any reflection from the petri dish. The average of 
the frames of the petri dish surface was saved to use as a mask 
to subtract to the tissues images. Healthy and cancer tissues 
from the same colon sample were placed in the same petri dish 
in succession. Optical images of the tissues were acquired by 
using a portable optical microscope (Dino-Lite AM3113T USB 
                                                
                                               
Fig. 2 Response of the optical system to FAD at six different concentrations. (a) Images of FAD solutions masked by the feature of the USAF target at concentrations 
of 7.5 µM, 15 µM, 30 µM, 60 µM, 125 µM, 250 µM. (b) Imaging feature in the USAF target (c) Average fluorescence intensity of the pixels within the square 
feature for each concentration was computed to assess the optical sensitivity of the system as a function of concentration. The data shows the mean of independent 
experiments (n = 3) and the error bars show the standard deviation.   
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Digital Microscope). Finally, a square area of the petri dish 
surrounding both the tissues was raster scanned on top of the 
optical system. Images were acquired for the full duration of the 
scan. The complete image of the tissues was reconstructed by 
horizontal and vertical superimposition of the frames acquired 
during the scan (Fig. S9, Supplementary Information). 
III. RESULTS AND DISCUSSION 
A. Optical System for Fluorescence Imaging 
A miniaturised optical block for fluorescence imaging in 
capsule endoscopy is presented. The block is made of 
aluminium and was realized by wire erosion process. It 
accommodates an LED, two lenses and three optical filters to 
separate excitation and green fluorescence light (Figs. 1a, 1b). 
The optics were designed to successfully separate the excitation 
light from green fluorescence light between 520 and 530 nm. 
As it is shown in Fig. 1 (c), in excitation mode, light from the 
LED, with a center wavelength of 468 nm and a 15° beam angle, 
was collimated and filtered onto the beam splitter placed at a 
45° angle. The excitation beam was reflected through the 
objective lens to the sample. In fluorescent mode, the 
fluorescent emission from the sample was imaged by the 
achromatic objective lens after passing through the 
fluorescence emission filter. The imager was completed using 
a 64x64 pixel SPAD array. The miniaturized imager could be 
easily integrated in capsules for endoscopy to image and detect 
small variations in the autofluorescence signal of the GI walls. 
Such measurements can be crucial for early cancer diagnosis. 
The power consumption of each component makes the system 
suitable for the integration in capsule format by using charge 
pump technology [23], [24].  The LED and the SPAD array 
consume 3mA and 5 mA respectively. With a 3V, 150 mAh 
battery the system will operate for approximately 17 hours.  The 
full imaging system described in the material and methods 
section was characterised by evaluating the crosstalk noise 
component which is the small amount of excitation light 
coming from the LED scattering on to the active area of the 
SPAD (Supplementary Information S7).  The average crosstalk 
noise from the LED was 435 cps.  
B. Imaging of FAD Phantom Solution 
As discussed in both the introduction and materials and 
methods sections, FAD is an endogenous fluorophore 
expressed in human tissues. Measurements were carried out on 
FAD salt hydrate dissolved in phosphate buffer saline to 
determine the minimum concentration of fluorophore in 
solution detectable by the system. Variation in the ratio between 
the oxidized form of FAD, with fluorescence emission peak 
between 525 and 530 nm, and its reduced form (FADH2), which 
does not emit any fluorescence, are directly linked to the 
metabolic activity within the tissues during carcinogenesis[25]. 
The increase of FADH2 over FAD is one of the causes of a 
reduced autofluorescence signal from cancer tissue [26].  Using 
a 625 µm x 625 µm feature in an USAF target to form a regular 
mask, the imaging system was tested to measure the 
fluorescence signal as a function of concentration. As can be 
seen in Fig. 2, count rates from the pixels within the square 
feature were reliably calculated indicating that the smallest 
measurable concentration was as little as 7.5µM.   
C. Detection of fluorescence-labelled colorectal cancer cells 
Accuracy in tumour diagnosis and assessment of cancer 
lesions is critical to disease treatment. A precise early detection 
of cancer can be achieved by targeting specific cells or 
molecules that are overexpressed and metabolized in tissues 
undergoing carcinogenesis[27]. In this work, we used a 
Gamma-glutamyl transpeptidase (GGT) selective fluorescence 
probe γ-glutamyl hydroxymethyl rhodamine green (gGlu-
HMRG) that is sold as ProteoGreenGluTM [16]. GGT is an 
enzyme expressed on cells membranes acting as catalyst in the 
cellular glutathione homeostasis. GGT expression is high on the 
membranes of several cancer cells and low in normal tissues. 
gGluHMRG does not show any fluorescence under low levels 
of GGT. However, the reaction with GGT on the membranes of 
cancer cells leads to the hydrolysis of gGluHMRG into 
hydrophobic HMRG which has a fluorescence signal with a 
peak at 525 nm. HMRG can freely pass through cells 
membranes and accumulate in lysosomes making the cells 
fluorescent. We assessed the capability of our optical system to 
detect fluorescence from colorectal cancer cells cultured in a 96 
well plate at four different seeding densities and separately 
labelled with Proteogreen gGluTM at three different 
concentrations. Fluorescence intensities from four wells 
cultured with the same cell line and labelled with the 
fluorescence dye Cell Tracker GreenTM, which is not cancer 
specific, were also measured to further characterise the system. 
A ModulusTM Microplate was used as reference instrument to 
measure fluorescence intensities from the cells and validate our 
device.  Figure 3 (a,c) shows the response of the imaging system 
and the ModulusTM instrument demonstrating an increase in the 
fluorescence signals from all the four seeding densities after 
being labelled with CellTrackerGreenTM. The cancer–selective 
probe Proteogreen gGluTM demonstrated a lower increase of the 
fluorescence signal than the CellTrackerGreenTM. As we can 
see from figure 3 (b,d), a clear fluorescence signal is obtained 
for seeding densities greater than 2 x 104 cell/cm2. The 
specificity of Proteogreen gGluTM for cancer cells was also 
validated by labelling a non-cancerous cell line of fibroblasts 
immortalized with hTERT. Figure 4 shows that there is no 
obvious increase in fibroblasts, labelled with 5 µM of the probe. 
We also directly compared the data from the miniaturised 
system and the ModulusTM microplate. As can be seen from 
figures S10 and S11 in the supplementary information section, 
the result is a linear plot with a correlation R2>90% at each 
concentration of the dyes indicating that our device has 
equivalent response to the large-scale commercialised system.  
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Fig. 3: Comparison of optical block and SPAD with ModulusTM microplate for detection of fluorescence from colorectal cancer cells cultured at seeding densities 
of 1562 cells/cm2, 6250 cells/cm2, 25,000 cells/cm2, 100,000 cells/cm2 and separately labelled with generic fluorescence probe (CellTracker™ Green CMFDA) 
and cancer-selective fluorescence probe (Proteogreen gGluTM). (a) Detection of fluorescence in colorectal cancer cells labelled with fluorescence probe 
CellTracker™ Green CMFDA at concentration of 5µM, 2µM and 1µM using our system.  (b) Detection of fluorescence in colorectal cancer cells labelled with 
cancer selective fluorescence probe Proteogreen gGluTM at concentration of 5µM, 2µM and 1µM using our system. (c) Detection of fluorescence in colorectal 
cancer cells labelled with fluorescence probe CellTracker™ Green CMFDA at concentration of 5µM, 2µM and 1µM using ModulusTM microplate (d) Detection 
of fluorescence in colorectal cancer cells labelled with fluorescence probe Proteogreen gGluTM  at concentration of 5µM, 2µM and 1µM  using ModulusTM 
microplate. Each seeding density was cultured four times in a 96 wells plate. All four wells were labelled and fluorescence value from each well was measured. 
The average of the four values from a plate was considered as an experimental replicate.  The experiments were replicated in three different plates for a total of 
three replicates per concentration of probe. Fluorescence intensities from three plates of cells without any fluorescence labelling were also measured.  
 
                           
Fig. 4: Response of optical system for capsule endoscopy to fibroblasts labelled with 5µM of the cancer-selective fluorescence probe (Proteogreen gGluTM) in 
comparison to colorectal cancer cells labelled with the same probe. (a) The plot depicts the measured values of fluorescence intensity from fibroblasts at seeding 
densities of 1562 cells/cm2, 6250 cells/cm2, 25,000 cells/cm2 and 100,000 cells/cm2 before and after fluorescence labelling with Proteogreen gGluTM. (b) The plot 
depicts the measured values of fluorescence intensity from colorectal cancer cells at seeding densities of 1562 cells/cm2, 6250 cells/cm2, 25,000 cells/cm2 and 
100,000 cells/cm2 after fluorescence labelling with 5µM of Proteogreen gGluTM. The increase in the fluorescence signal from colon cancer cell line after labelling 
is more pronounced at the highest seeding density. The experiments were replicated in three different plates. 
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D.  Autofluorescence imaging of human healthy colon 
mucosa and human adenocarcinoma of the colon 
Samples from four different patients with adenocarcinoma of 
the colon were collected after hemicolectomy to obtain 
autofluorescence images of healthy colon mucosa and tumour 
tissues. Healthy colon mucosa has three main layers defined as 
mucosa, submucosa and muscolaris propria. Submucosa is 
reported to be the most fluorescent component[28].  
Autofluorescene images from eight samples revealed 
differences in the clinically measured autofluorescence 
intensities between normal and tumour tissue (Fig. 5). No 
difference could be seen in the white light optical images. The 
autofluorescence from healthy colon mucosa was always 
higher.  
We attribute the observed data to increased haemoglobin 
absorption in cancerous tissues as well as to the fact that 
carcinogenesis is responsible for an increase in thickness of the 
tumour mucosa and thus a decrease in the fluorescence signal 
from the submucosa[29]. It has been shown that gGlu-HMRG 
is not effective when used to label resected colon cancer tissues 
hence we did not study its performance in this work[12]. 
IV. CONCLUSION 
Fluorescence imaging has the potential to significantly 
improve capsule endoscopy by reducing the error rate in the 
detection of cancer. We have developed a fluorescence imager 
with dimensions suitable for integration into capsule 
endoscopy. The optical module was fabricated by using widely 
available and low-cost manufacturing processes. The system 
comprising a new miniaturised optical block and a 64 x 64 
SPAD array was used to detect green fluorescence from FAD 
that is an endogenous fluorophore responsible for 
autofluorescence in human tissues. Fluorescence from 
colorectal cancer cells labelled with a cancer specific molecular 
probe was detected at three different concentrations of the 
labelling-probe. The results we obtained compared favourably 
with a large bench-top conventional system. Clinical studies 
performed using resected malignant tissues from the human 
colon demonstrated a clear distinction in endogenous 
autofluorescence between normal and malignant tissues. We 
attribute the reduction in the signal to either conversion of FAD 
to FADH2 in the tumour or to the thickening of the mucosal 
layer either of which is associated with cancer tissues. Increased 
presence of haemoglobin as a consequence of vascularization 
in tumours may also have been a factor. The highly miniaturised 
nature of the device demonstrates the technology’s potential use 
in capsule endoscopy  
ACKNOWLEDGMENT 
This work was funded by the centre for doctoral training (CDT) 
in intelligent sensing and measurements (ISM) and was carried 
out as part of the SONOPILL project funded by the Engineering 
and Physical Sciences Research Council (EPSRC), UK 
(EP/K034537/1).  
REFERENCES 
[1]  Gavriel Iddan,  Gavriel Meron,  Arkady Glukhovsky, 
and  Paul Swain, “Wireless capsule endoscopy,” 
Nature, vol. 405, no. 6785, 2000. 
[2] B. S. Lewis, G. M. Eisen, and S. Friedman, “A pooled 
analysis to evaluate results of capsule endoscopy 
trials,” Endoscopy, vol. 37, no. 10, p. 960—965, Oct. 
2005. 
[3] J. Haringsma et al., “Autofluorescence endoscopy: 
Feasibility of detection of GI neoplasms unapparent to 
white light endoscopy with an evolving technology,” 
Gastrointest. Endosc., vol. 53, no. 6, pp. 642–650, 
2001. 
                                                
                                     
 
Fig. 5: Measures of autofluorescence intensities from healthy colon mucosa and tissues from adenocarcinoma of the colon. Comparison between white light images 
and autofluorescence (AF) images of human adenocarcinoma tissue and human healthy colon mucosa from four different patients (a), (b), (c), (d). AF images were 
acquired with the optical block and the CMOS SPAD array. AF images show higher autofluorescence signal in healthy mucosa with respect to cancerous tissues. 
Tissues samples were collected from four different patients undergoing hemicolectomy procedures. Experiments were performed within 30 minutes of the 
operation. Autofluorescence images were obtained by placing both healthy and cancerous tissues on the same petri dish and scanning the whole area of the petri 
dish containing the tissues. Frames from the scans where stitched together to create the full images. 
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
8 
[4] W. L. Curvers et al., “Endoscopic tri-modal imaging 
for detection of early neoplasia in Barrett ’ s 
oesophagus : a multi-centre feasibility study using 
high-resolution endoscopy , autofluorescence imaging 
and narrow band imaging incorporated in one 
endoscopy system.” 
[5] “World’s First Gastrointestinal Videoendoscopes with 
Auto Fluorescence Imaging Capability.” 
[6] S. M. Bae et al., “Multi-Spectral Fluorescence 
Imaging of Colon Dysplasia InVivo Using a Multi-
Spectral Endoscopy System,” Transl. Oncol., vol. 12, 
no. 2, pp. 226–235, Nov. 2018. 
[7] K. Moriichi, M. Fujiya, and T. Okumura, “The 
efficacy of autofluorescence imaging in the diagnosis 
of colorectal diseases,” Clin. J. Gastroenterol., vol. 9, 
no. 4, pp. 175–183, 2016. 
[8] M. Filip, S. Iordache, A. Săftoiu, and T. Ciurea, 
“Autofluorescence imaging and magnification 
endoscopy.,” World J. Gastroenterol., vol. 17, no. 1, 
pp. 9–14, Jan. 2011. 
[9] Y. Urano et al., “Rapid Cancer Detection by Topically 
Spraying a g -Glutamyltranspeptidase – Activated 
Fluorescent Probe,” vol. 3, no. 110, 2011. 
[10] Q. T. Nguyen, E. S. Olson, T. A. Aguilera, T. Jiang, 
M. Scadeng, and L. G. Ellies, “Surgery with molecular 
fl uorescence imaging using activatable cell-
penetrating peptides decreases residual cancer and 
improves survival,” pp. 1–6, 2009. 
[11] T. Terai and T. Nagano, “Small-molecule 
fluorophores and fluorescent probes for bioimaging,” 
pp. 347–359, 2013. 
[12] H. Matsuzaki, M. Kamiya, R. J. Iwatate, D. Asanuma, 
T. Watanabe, and Y. Urano, “Novel Hexosaminidase-
Targeting Fluorescence Probe for Visualizing Human 
Colorectal Cancer,” Bioconjug. Chem., vol. 27, no. 4, 
pp. 973–981, Apr. 2016. 
[13] M. Mitsunaga et al., “Fluorescence endoscopic 
detection of murine colitis-associated colon cancer by 
topically applied enzymatically rapid-activatable 
probe,” pp. 1179–1186, 2013. 
[14] K. Kawakami et al., “Gamma-glutamyltransferase 
activity in exosomes as a potential marker for prostate 
cancer,” pp. 1–12, 2017. 
[15] C. Sato et al., “A Pilot Study of Fluorescent Imaging 
of Colorectal Tumors Using a &#947;-Glutamyl-
Transpeptidase-Activatable Fluorescent Probe,” 
Digestion, vol. 91, no. 1, pp. 70–76, 2015. 
[16] M. Ryou et al., “An implantable wireless biosensor for 
the immediate detection of upper GI bleeding : a new 
fluorescein-based tool for diagnosis and surveillance ( 
with video ),” YMGE, vol. 74, no. 1, pp. 189-194.e1, 
2011. 
[17] T. D. O. Sullivan et al., “Real-time , continuous , 
fluorescence sensing in a freely-moving subject with 
an implanted hybrid VCSEL / CMOS biosensor,” vol. 
4, no. 8, pp. 1332–1341, 2013. 
[18] P. Demosthenous, C. Pitris, J. Georgiou, and S. 
Member, “Infrared Fluorescence-Based Cancer 
Screening Capsule for the Small Intestine,” IEEE 
Trans. Biomed. Circuits Syst., vol. 10, no. 2, pp. 467–
476, 2016. 
[19] M. a. Al-Rawhani, J. Beeley, and D. R. S. Cumming, 
“Wireless fluorescence capsule for endoscopy using 
single photon-based detection,” Sci. Rep., vol. 5, no. 
November, p. 18591, 2015. 
[20] Z. Li, Z. Liao, and M. McAlindon, Handbook of 
capsule endoscopy. 2014. 
[21] A. Nemeth, Role of capsule endoscopy in small bowel 
management. Lund University, 2019. 
[22] C. Accarino et al., “A 64x64 SPAD array for portable 
colorimetric sensing, fluorescence and x-ray imaging,” 
IEEE Sens. J., p. 1, 2019. 
[23] L.-R. Dung and Y.-Y. Wu, “A wireless narrowband 
imaging chip for capsule endoscope,” IEEE Trans. 
Biomed. Circuits Syst., vol. 4, no. 6, pp. 462–468, 
2010. 
[24] X. Chen et al., “A wireless capsule endoscope system 
with low-power controlling and processing ASIC,” 
IEEE Trans. Biomed. Circuits Syst., vol. 3, no. 1, pp. 
11–22, 2009. 
[25] W. Becker, A. Bergmann, R. S. Ibarrola, P.-F. Müller, 
and L. Braun, “Metabolic imaging by simultaneous 
FLIM of NAD(P)H and FAD,” in Proc.SPIE, 2019, 
vol. 10882, no. 
[26] O. I. Kolenc and K. P. Quinn, “Evaluating Cell 
Metabolism Through Autofluorescence,” vol. 30, no. 
6, pp. 875–889, 2019. 
[27] H. Kobayashi and P. L. Choyke, “Target-cancer-cell-
specific activatable fluorescence imaging probes: 
rational design and in vivo applications.,” Acc. Chem. 
Res., vol. 44, no. 2, pp. 83–90, Feb. 2011. 
[28] G. Bottiroli, A. C. Croce, and D. Locatelli, “Natural 
Fluorescence of Normal and Neoplastic Human 
Colon : A Comprehensive ‘ Ex Vivo ’ Study,” vol. 60, 
1995. 
[29] Z. A. Steelman, D. S. Ho, K. K. Chu, and A. Wax, 
“Light-scattering methods for tissue diagnosis,” 
Optica, vol. 6, no. 4, pp. 479–489, Apr. 2019. 
 
